CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Cash & Equivalents (2021 - 2026)

CDT Equity's (CDT) quarterly Cash & Equivalents came in at $97000.0 in Q1 2026, down 95.45% YoY from $2.1 million in Q1 2025, and down 93.57% on a QoQ basis from $1.5 million in Q4 2025.

CDT Equity (CDT) Cash & Equivalents (2021 - 2026) Analysis & Trends

CDT Equity (CDT) has 6 years of Cash & Equivalents data on file, last reported at $97000.0 in Q1 2026.

  • Quarterly Cash & Equivalents fell 95.45% year-over-year to $97000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97000.0 (down 95.45% YoY) and the FY2025 annual result came in at $1.5 million, up 151.5% from the prior year.
  • Cash & Equivalents slipped to $97000.0 in Q1 2026, from $1.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $8.6 million in Q3 2023 to a low of $71000.0 in Q3 2024.
  • A 5-year average of $1.7 million and a median of $837687.0 in 2022 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents sank 99.18% — and 2025, when it surged 5252.11%.
  • Tracing CDT's Cash & Equivalents over 5 years: stood at $345777.0 in 2022, then surged by 1122.75% to $4.2 million in 2023, then plunged by 85.81% to $600000.0 in 2024, then surged by 151.5% to $1.5 million in 2025, then plunged by 93.57% to $97000.0 in 2026.
  • The last three Cash & Equivalents figures came in at $97000.0 (Q1 2026), $1.5 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 CDT Equity 1.55 Mn 1.55 Mn - 747,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 747,000.00
Mar 31, 2026 97,000.00
Dec 31, 2025 1.51 Mn
Sep 30, 2025 3.80 Mn
Jun 30, 2025 3.33 Mn
Mar 31, 2025 2.13 Mn
Dec 31, 2024 600,000.00
Sep 30, 2024 71,000.00
Jun 30, 2024 219,000.00
Mar 31, 2024 1.84 Mn
Dec 31, 2023 4.23 Mn
Sep 30, 2023 8.64 Mn
Jun 30, 2023 277,761.00
Mar 31, 2023 90,606.00
Dec 31, 2022 345,777.00
Sep 30, 2022 728,072.00
Jun 30, 2022 837,687.00
Mar 31, 2022 964,602.00
Dec 31, 2021 48,555.00